Aaron Davis is Co-Founder and Chief Executive Officer of Boxer Capital, LLC. In 2005, after joining Tavistock Group as Portfolio Manager, Mr. Davis scaled Tavistock Group’s public healthcare investing activities and formed Boxer Capital. Mr. Davis leads the firm’s research team, deal structuring, and portfolio management.
Mr. Davis is currently Chairman of the Board of CiVi Biopharma and is a Member of the Board of Directors of iTeos Therapeutics, Mirati Therapeutics, Odonate Therapeutics, Sojournix, Inc., and Tango Therapeutics.
Prior to joining Tavistock Group, Mr. Davis worked in the Global Healthcare Investment Banking and Private Equity Group at UBS Warburg, LLC. During this period, Mr. Davis led strategic transactions for public and private biotechnology and medical device companies throughout their growth, advising on financing and mergers and acquisitions. Having also served in various roles with biotechnology and venture capital firms, Mr. Davis has extensive expertise in investment analysis and in overseeing in-licensing activities within the pharmaceutical sector.
Mr. Davis holds a Master of Science in Biotechnology from Columbia University and a Bachelor of Arts in Business Administration from Emory University.
What is Aaron I. Davis' net worth?
The estimated net worth of Aaron I. Davis is at least $0.00 as of November 4th, 2022. Mr. Davis owns 2,147,212 shares of Odonate Therapeutics stock worth more than $0 as of May 6th. This net worth evaluation does not reflect any other investments that Mr. Davis may own. Learn More about Aaron I. Davis' net worth.
How do I contact Aaron I. Davis?
Has Aaron I. Davis been buying or selling shares of Odonate Therapeutics?
Aaron I. Davis has not been actively trading shares of Odonate Therapeutics during the last ninety days. Most recently, Aaron I. Davis sold 30,000 shares of the business's stock in a transaction on Friday, November 19th. The shares were sold at an average price of $1.92, for a transaction totalling $57,600.00. Learn More on Aaron I. Davis' trading history.
Who are Odonate Therapeutics' active insiders?
